Politics of Cancer

//Politics of Cancer

Political happenings that are related to Cancer

The House Passes The 21st Century Cures Act – On To The Senate

Last Wednesday the House passed with a vote of 392 to 26, a medical innovation bill known as the 21st Century Cures Act, aimed at curing diseases, with the measure securing bipartisan support after months of negotiations. The bill’s goals are to speed up the Food and Drug Administration’s approval of new drugs while also investing new money in medical research. The package also includes a range of other healthcare priorities, including $1 billion over two years to fight the epidemic of opioid addiction and $1.8 billion for Vice President Biden’s cancer “moonshot.” The cures legislation also includes a mental health [...]

By | December 1st, 2016|Cancer Moon Shot, FDA, Politics of Cancer, Research, Uncategorized|0 Comments

POM Wonderful Misled Its Customers – Do You Take Pomegranate Juice or Supplements?

Many of us have believed that pomegranate juice like POM Wonderful and POMx supplements treat, prevent or reduce the risk of heart disease, prostate cancer or erectile dysfunction?  The simple truth is that this assertion has been called into question and might not be true! According to the Federal Trade Commission and a decision by a U.S. federal court, pomegranate juice and supplements might not be the heaven sent elixir we have been led to believe. In a decision by the FTC: The company POM Wonderful that makes POM cannot state such claims in their advertising. This FTC decision was appealed to [...]

By | October 25th, 2016|Politics of Cancer, supplements, Uncategorized|0 Comments

For USA readers – Protect Our Department of Defense Prostate Cancer Funding

UPDATE June &, 2016 4:30 PM EST We won. The Durbin Amendment to save all cancer research funding at the Department of Defense passed 66-32, saving the Congressionally Directed Medical Research Program (CDMRP), which includes an important prostate cancer funding resource. Thank you to everyone from Malecare Cancer Support and all of our partner organizations for sending in your emails and making your phone calls. Three cheers for you! To see how your Senators voted on this important matter go to the bottom of this post.  If your Senator voted YEA send an email thanking them.  However, if they voted [...]

By | June 2nd, 2016|DOD, DOD PCRP, Politics of Cancer, United States|0 Comments

Myriad Genetics Attempts To Deny Patients Their Personal Genetic Information

 In 2013, Myriad Genetic failed – in a case that was heard in the United States Supreme Court - to patent the BRCA1 and BRCA2 genes.  We all have these two genes which, when they mutate, are associated with breast, ovarian and prostate cancers. If Myriad succeeded, they would have controlled patents on these genes and could establish a monopoly on all research and testing of these genes. Myriad is now facing a lawsuit over  denying their clients access to their own genetic information.  The four plaintiffs in the action underwent genetic testing with Myriad to determine their hereditary risk [...]

スーパーコピーブランド ロレックススーパーコピー オメガスーパーコピー ブルガリスーパーコピー ブライトリングスーパーコピー カルティエスーパーコピー シャネル時計コピー IWCスーパーコピー フランクミュラースーパーコピー パネライスーパーコピー タグホイヤースーパーコピー ウブロスーパーコピー ガガミラノスーパーコピー ルイヴィトンスーパーコピー シャネルスーパーコピー エルメススーパーコピー グッチスーパーコピー ボッテガヴェネタスーパーコピー プラダスーパーコピー セリーヌスーパーコピー ロレックススーパーコピー ウブロスーパーコピー